Literature DB >> 34550729

Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers.

C Glenn Begley1, Mark Ashton2, Jonathan Baell3, Michael Bettess4, Michael P Brown5, Brett Carter6, William N Charman3, Christopher Davis7, Simon Fisher8, Ian Frazer9, Anand Gautam10, Michael P Jennings7, Philip Kearney11, Eloise Keeffe7, Darren Kelly12, Angel F Lopez13, Michael McGuckin14, Michael W Parker15, Craig Rayner16, Brett Roberts8, James S Rush17, Mark Sullivan18.   

Abstract

Drug repurposing is promoted as a cost- and time-effective mechanism for providing new medicines. Often, however, there is insufficient consideration by academic researchers of the processes required to ensure that a repurposed drug can be used for a new indication. This may explain the inability of drug repurposing to fulfill its promise. Important aspects, often overlooked, include financial and intellectual property considerations, the clinical and regulatory path, and clinical equipoise, which provides ethical justification for randomized controlled trials. The goal of drug repurposing is to obtain a new regulator-approved label for an existing drug, and so, the trajectory for drug repurposing and traditional drug development is similar. Here, we discuss factors critical for a successful repurposed medicine to help academic investigators better identify drug repurposing opportunities.

Entities:  

Mesh:

Year:  2021        PMID: 34550729     DOI: 10.1126/scitranslmed.abd5524

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  9 in total

Review 1.  Ten challenges for clinical translation in psychiatric genetics.

Authors:  Eske M Derks; Jackson G Thorp; Zachary F Gerring
Journal:  Nat Genet       Date:  2022-09-22       Impact factor: 41.307

Review 2.  Mitophagy and reactive oxygen species interplay in Parkinson's disease.

Authors:  Bin Xiao; Joshua Kuruvilla; Eng-King Tan
Journal:  NPJ Parkinsons Dis       Date:  2022-10-18

3.  Social Media and COVID-19-Perceptions and Public Deceptions of Ivermectin, Colchicine and Hydroxychloroquine: Lessons for Future Pandemics.

Authors:  Natalie Schellack; Morné Strydom; Michael S Pepper; Candice L Herd; Candice Laverne Hendricks; Elmien Bronkhorst; Johanna C Meyer; Neelaveni Padayachee; Varsha Bangalee; Ilse Truter; Andrea Antonio Ellero; Thulisa Myaka; Elysha Naidoo; Brian Godman
Journal:  Antibiotics (Basel)       Date:  2022-03-25

4.  Drug repositioning in non-small cell lung cancer (NSCLC) using gene co-expression and drug-gene interaction networks analysis.

Authors:  Habib MotieGhader; Parinaz Tabrizi-Nezhadi; Mahshid Deldar Abad Paskeh; Behzad Baradaran; Ahad Mokhtarzadeh; Mehrdad Hashemi; Hossein Lanjanian; Seyed Mehdi Jazayeri; Masoud Maleki; Ehsan Khodadadi; Sajjad Nematzadeh; Farzad Kiani; Mazaher Maghsoudloo; Ali Masoudi-Nejad
Journal:  Sci Rep       Date:  2022-06-08       Impact factor: 4.996

5.  Can repurposing drugs play a role in malaria control?

Authors:  Roland A Cooper; Laura Kirkman
Journal:  J Exp Med       Date:  2021-11-22       Impact factor: 17.579

6.  Combination Therapy of Ledipasvir and Itraconazole in the Treatment of COVID-19 Patients Coinfected with Black Fungus: An In Silico Statement.

Authors:  Supriyo Saha; Gyu Seong Yeom; Satish Balasaheb Nimse; Dilipkumar Pal
Journal:  Biomed Res Int       Date:  2022-04-19       Impact factor: 3.246

Review 7.  Inhibitors of SARS-CoV-2 PLpro.

Authors:  Dale J Calleja; Guillaume Lessene; David Komander
Journal:  Front Chem       Date:  2022-04-26       Impact factor: 5.545

8.  Insights Into Drug Repurposing, as Well as Specificity and Compound Properties of Piperidine-Based SARS-CoV-2 PLpro Inhibitors.

Authors:  Dale J Calleja; Nathan Kuchel; Bernadine G C Lu; Richard W Birkinshaw; Theresa Klemm; Marcel Doerflinger; James P Cooney; Liana Mackiewicz; Amanda E Au; Yu Q Yap; Timothy R Blackmore; Kasiram Katneni; Elly Crighton; Janet Newman; Kate E Jarman; Melissa J Call; Bernhard C Lechtenberg; Peter E Czabotar; Marc Pellegrini; Susan A Charman; Kym N Lowes; Jeffrey P Mitchell; Ueli Nachbur; Guillaume Lessene; David Komander
Journal:  Front Chem       Date:  2022-04-12       Impact factor: 5.545

Review 9.  AlphaFold, Artificial Intelligence (AI), and Allostery.

Authors:  Ruth Nussinov; Mingzhen Zhang; Yonglan Liu; Hyunbum Jang
Journal:  J Phys Chem B       Date:  2022-08-17       Impact factor: 3.466

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.